FDA's role in coordinating emergency and crisis response activities involving regulated products.
Medical Countermeasures Initiative (MCMi)
MCMi is an FDA-wide initiative to coordinate medical countermeasure (MCM) development, preparedness, and response.Learn More
Counterterrorism and Emerging Threats
FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats.
Novel coronavirus (COVID-19)
FDA is employing our public health authorities to facilitate development & availability of medical countermeasures to help address this outbreak.
Ebola Preparedness and Response Updates
FDA is working to help expedite the development and availability of medical products with the potential to help bring Ebola outbreaks under control as quickly as possible.
A free online course on using Incident Command System (ICS) principles in incidents involving FDA-regulated products.Learn More